Samsung Medical Center

AUG 20, 2026 · PHASE 4 TRIAL

Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF

ClinicalTrials.gov

This is a registered clinical trial currently recruiting with no results posted; it represents a planned Phase 4 study addressing an understudied question about SGLT2 inhibitors and rhythm maintenance post-cardioversion.

AUG 19, 2026 · PHASE 2 TRIAL

A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy

ClinicalTrials.gov

This is a Phase 2 registry record with no reported results; the study is actively recruiting and designed to test a hypothesis about dose reduction and supplementation to prevent a known toxicity.

AUG 12, 2026 · OBSERVATIONAL STUDY

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

ClinicalTrials.gov

This is a registry record for an ongoing molecular screening study with no reported results; it describes planned enrollment and methodology only, making it a feasibility and characterization effort preceding intervention trials.

AUG 10, 2026 · OBSERVATIONAL STUDY

SMC Radiation Oncology Breast Cancer Cohort Study

ClinicalTrials.gov

This is an active observational cohort study with planned enrollment of 500 participants tracking cosmesis and fibrosis outcomes over 5 years; no results are reported in this registry record.

AUG 7, 2026 · OBSERVATIONAL STUDY

Association of Heart Failure Aggravation and Device-based Sensor Parameters

ClinicalTrials.gov

This is an active observational registry study with no reported results; it is designed to evaluate associations between device sensors and heart failure worsening but outcome data are not yet published.